| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0197-2456(99)00031-8 |
| P8608 | Fatcat ID | release_ghxkuftqxrh6ximxqvrntmle5e |
| P932 | PMC publication ID | 1473211 |
| P698 | PubMed publication ID | 10588299 |
| P50 | author | Age-Related Eye Disease Study Research Group | Q83234373 |
| P2860 | cites work | Senile macular degeneration: a preliminary study | Q70470159 |
| Zinc lowers high-density lipoprotein-cholesterol levels | Q71335391 | ||
| Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group | Q72093526 | ||
| The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study | Q73043468 | ||
| Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group | Q73440318 | ||
| Clinical trials and treatment effects monitoring | Q77754806 | ||
| Global data on blindness | Q24654026 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| A Multiple Testing Procedure for Clinical Trials | Q28248823 | ||
| Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease | Q29616095 | ||
| The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers | Q29616096 | ||
| Tutorial in biostatistics methods for interval-censored data | Q32108424 | ||
| Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease | Q34375385 | ||
| Two eyes or one? The data analyst's dilemma. | Q36436670 | ||
| Comparing incomplete paired binomial data under non-random mechanisms | Q36436779 | ||
| A proportional hazards model for interval-censored failure time data. | Q36483123 | ||
| Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model | Q36795135 | ||
| Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts | Q39309664 | ||
| The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study | Q39820430 | ||
| The Wisconsin age-related maculopathy grading system | Q41902806 | ||
| Marginal models for correlated binary responses with multiple classes and multiple levels of nesting | Q43503890 | ||
| Do we have a nutritional treatment for age-related cataract or macular degeneration? | Q44641331 | ||
| Senile macular degeneration and risk factors: a case-control study | Q45218111 | ||
| Vitamin E consumption and the risk of coronary disease in women. | Q50126258 | ||
| Senile macular degeneration: a case-control study. | Q50927753 | ||
| Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. | Q51650990 | ||
| Sample sizes for long-term medical trial with time-dependent dropout and event rates. | Q52757110 | ||
| Implementation of group sequential logrank tests in a maximum duration trial. | Q52865798 | ||
| Shall We Count Numbers of Eyes or Numbers of Subjects? | Q52956989 | ||
| Photocoagulation for Diabetic Macular Edema | Q60358385 | ||
| Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67660771 | ||
| Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group | Q67660776 | ||
| Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group | Q67696853 | ||
| Zinc supplements and serum lipids in young adult white males | Q67921365 | ||
| Oral zinc in macular degeneration | Q68126625 | ||
| The Lens Opacities Case-Control Study. Risk factors for cataract | Q68193002 | ||
| Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group | Q68957138 | ||
| Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group | Q69874090 | ||
| Relationship between zinc intake, physical activity, and blood levels of high-density lipoprotein cholesterol in a healthy elderly population | Q70116620 | ||
| Ocular and facial skin exposure to ultraviolet radiation in sunlight: a personal exposure model with application to a worker population | Q70213689 | ||
| Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group | Q70215925 | ||
| Standardized illumination for visual acuity testing in clinical research | Q70389079 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 573-600 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Contemporary Clinical Trials | Q5164971 |
| P1476 | title | The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | |
| P478 | volume | 20 |
| Q52818918 | A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. |
| Q93150652 | A multi-task deep learning model for the classification of Age-related Macular Degeneration |
| Q24546140 | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 |
| Q24544001 | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 |
| Q33849399 | A risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts |
| Q78032752 | A trawl through the current nutrition literature |
| Q36069565 | AMD and micronutrient antioxidants. |
| Q49606437 | AREDS simplified severity scale as a predictive factor for response to aflibercept therapy for typical neovascular age-related macular degeneration. |
| Q36223020 | Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study |
| Q42565175 | Advances in technology helps in early detection of vision disorders |
| Q33263472 | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts |
| Q34999044 | Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. |
| Q85370117 | Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24202824 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration |
| Q24246241 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration |
| Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
| Q31035634 | Antioxidants in prevention of cataracts in South India: methodology and baseline data*. |
| Q48262215 | Approaches by the US National Institutes of Health to support rigorous scientific research on dietary supplements and natural products |
| Q98577941 | Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD |
| Q36985901 | Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice |
| Q34052504 | Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. |
| Q56243498 | Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study |
| Q92524759 | Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39 |
| Q48553385 | Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. |
| Q47335501 | Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration |
| Q89919429 | Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMD |
| Q35221016 | Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration |
| Q34655512 | Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 |
| Q35826745 | Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration |
| Q42158868 | Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle |
| Q38877436 | Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores |
| Q37013392 | C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration |
| Q33979055 | C3 R102G polymorphism increases risk of age-related macular degeneration |
| Q38818680 | CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. |
| Q36095440 | CX3CR1 polymorphisms and the risk of age-related macular degeneration |
| Q37192985 | Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS) |
| Q26738776 | Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans |
| Q35762167 | Centrum use and progression of age-related cataract in the Age-Related Eye Disease Study: a propensity score approach. AREDS report No. 21 |
| Q33502975 | Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. |
| Q35554026 | Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34 |
| Q37365628 | Changes in the quality-of-life of people with keratoconus |
| Q47097580 | Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration |
| Q36187463 | Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. |
| Q90602223 | Copula-based score test for bivariate time-to-event data, with application to a genetic study of AMD progression |
| Q35027522 | Copy number variations in candidate genes in neovascular age-related macular degeneration |
| Q34655550 | Correlation analysis of the in-clinic and telephone batteries from the AREDS cognitive function ancillary study. AREDS Report No. 15 |
| Q38611218 | Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data |
| Q90752324 | Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis |
| Q29614503 | Database resources of the National Center for Biotechnology Information |
| Q91879189 | Deep-learning-based Prediction of Late Age-Related Macular Degeneration Progression |
| Q34240119 | Detecting rare haplotype-environment interaction with logistic Bayesian LASSO |
| Q34978847 | Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study |
| Q36728621 | Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study |
| Q38529695 | Dietary modification and supplementation for the treatment of age-related macular degeneration |
| Q35870337 | Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes |
| Q36591612 | Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents |
| Q35005964 | Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility |
| Q58566804 | Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration |
| Q37627216 | Drusen volume development over time and its relevance to the course of age-related macular degeneration. |
| Q38385726 | Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial |
| Q64885236 | Emergence of dual VEGF and PDGF antagonists in the treatment of exudative age-related macular degeneration. |
| Q40048038 | Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small |
| Q90532319 | Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degeneration |
| Q64091935 | Fundus autofluorescence and retinal sensitivity in fellow eyes of age-related macular degeneration in Japan |
| Q34142148 | Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium |
| Q36494293 | Gene-Based Association Analysis for Censored Traits Via Fixed Effect Functional Regressions |
| Q36849277 | Genetic Association Analysis of Drusen Progression |
| Q33530081 | Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration |
| Q49963850 | Genome-wide Analysis of Disease Progression in Age-related Macular Degeneration. |
| Q34930448 | Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration |
| Q34924529 | Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium |
| Q42727637 | Geographic atrophy in age-related macular degeneration and TLR3. |
| Q36165327 | Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization |
| Q33307521 | Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration |
| Q38807163 | Heritability of Choroidal Thickness in the Amish. |
| Q41661658 | Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study |
| Q35897928 | Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography. |
| Q88506719 | Impact of drusen and drusenoid retinal pigment epithelium elevation size and structure on the integrity of the retinal pigment epithelium layer |
| Q36811078 | Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen |
| Q36834417 | Implementation of evidence-based practice in optometry |
| Q36961648 | Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy |
| Q30448959 | Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training |
| Q90483327 | Influence of mydriasis on optical coherence tomography angiography imaging in patients with age-related macular degeneration |
| Q46906619 | Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions |
| Q90626363 | Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration |
| Q33844950 | Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms |
| Q36803690 | Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. |
| Q34402769 | Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria |
| Q51527934 | Logistic Bayesian LASSO for identifying association with rare haplotypes and application to age-related macular degeneration. |
| Q34666874 | Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. |
| Q37314763 | Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration |
| Q36963548 | Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues |
| Q36585741 | Matrix metalloproteinases and educational attainment in refractive error: evidence of gene-environment interactions in the Age-Related Eye Disease Study |
| Q40444321 | Measurement of stray light and glare: comparison of Nyktotest, Mesotest, stray light meter, and computer implemented stray light meter |
| Q38064846 | Mechanism of inflammation in age-related macular degeneration |
| Q33443895 | Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration |
| Q39633569 | Monomeric C-reactive protein and inflammation in age-related macular degeneration |
| Q37312888 | Multilocus analysis of age-related macular degeneration |
| Q47211512 | Mutations in MERTK are not associated with age-related macular degeneration |
| Q34655531 | National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10 |
| Q35865399 | Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. |
| Q34164826 | Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. |
| Q45921085 | Neovascular AMD: an overlooked risk factor for injurious falls. |
| Q34620551 | No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 |
| Q24201838 | Omega 3 fatty acid supplementation for preventing and slowing the progression of age-related macular degeneration |
| Q24186584 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
| Q24197544 | Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration |
| Q96577416 | Ophthalmic image acquired by ophthalmologists and by allied health personnel as part of a telemedicine strategy: a comparative study of image quality |
| Q38605292 | Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration |
| Q24793439 | Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12 |
| Q93017085 | Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort |
| Q34266458 | Peripheral autofluorescence findings in age-related macular degeneration |
| Q37578648 | Population-based survey of prevalence, causes, and risk factors for blindness and visual impairment in an aging Chinese metropolitan population |
| Q28084495 | Practical issues in screening and variable selection in genome-wide association analysis |
| Q99239361 | Predicting risk of late age-related macular degeneration using deep learning |
| Q37395594 | Preliminary analysis of the relationship between serum lutein and zeaxanthin levels and macular pigment optical density |
| Q98195448 | Prevalence and associated factors of visual impairment among adults at Debre Berhan town, North Shewa, Ethiopia |
| Q44154414 | Prevalence of impairment of visual function in European drivers |
| Q34949989 | Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors |
| Q33996503 | Progression of geographic atrophy and genotype in age-related macular degeneration |
| Q93000295 | Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment |
| Q74000122 | Prospective study of zinc intake and the risk of age-related macular degeneration |
| Q80174986 | Pulsatile ocular blood flow of choroidal neovascularization in asymmetric age-related macular degeneration after transpupillary thermotherapy |
| Q40240534 | Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis |
| Q35121750 | Quantitative analysis of cone photoreceptor distribution and its relationship with axial length, age, and early age-related macular degeneration |
| Q34449898 | Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. |
| Q37304476 | Regional replication of association with refractive error on 15q14 and 15q25 in the Age-Related Eye Disease Study cohort |
| Q35906882 | Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis |
| Q34655503 | Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14 |
| Q90462769 | Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells |
| Q37323307 | Rhesus monkeys and humans share common susceptibility genes for age-related macular disease |
| Q24545563 | Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 |
| Q34084938 | Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. |
| Q35228091 | Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. |
| Q24554181 | Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 |
| Q38696053 | Risk of Deficiency in Multiple Concurrent Micronutrients in Children and Adults in the United States. |
| Q34491990 | Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. |
| Q91994298 | Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases |
| Q34020735 | Set-based joint test of interaction between SNPs in the VEGF pathway and exogenous estrogen finds association with age-related macular degeneration |
| Q91620109 | Spatial-sweep steady-state pattern electroretinography can detect subtle differences in visual function among healthy adults |
| Q36508205 | Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration |
| Q38843440 | Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis |
| Q34657946 | Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q51210154 | Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33. |
| Q43796210 | The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. |
| Q34651797 | The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2 |
| Q35798037 | The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37 |
| Q57487253 | The Carnitine Shuttle Pathway is Altered in Patients With Neovascular Age-Related Macular Degeneration |
| Q37030323 | The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples |
| Q24678569 | The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples |
| Q92982650 | The Role of Fish Oil in Inflammatory Eye Diseases |
| Q42840566 | The SERPING1 gene and age-related macular degeneration |
| Q36076822 | The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. |
| Q34006113 | The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration |
| Q34623556 | The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. |
| Q46812060 | The effect of photodynamic therapy on retrobulbar blood flow parameters |
| Q47973997 | The influence of the refractive correction on the vision-related quality of life in keratoconus patients |
| Q36924781 | The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials |
| Q37160745 | The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole |
| Q33613367 | The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 |
| Q33914613 | The relationship of major American dietary patterns to age-related macular degeneration |
| Q37315329 | The steroids for corneal ulcers trial: study design and baseline characteristics |
| Q34777979 | The value of randomized clinical trials in ophthalmology |
| Q38471019 | Time trends in personnel certification and turnover in the Collaborative Ocular Melanoma Study |
| Q37061531 | Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration |
| Q36377905 | Tutorial on Biostatistics: Statistical Analysis for Correlated Binary Eye Data |
| Q91640890 | Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration |
| Q43662311 | Use of vitamin supplements and cataract: the Blue Mountains Eye Study |
| Q37482393 | Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. |
| Q28741677 | Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration |
| Q34493282 | Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27 |
| Q37715254 | Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration |
| Q86603541 | [Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014] |
| Q37421203 | {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study |
Search more.